Erika Hamilton, MD · @ErikaHamilton9
75 followers · 249 posts · Server med-mastodon.com
RT @OncBrothers@twitter.com
3 new drugs/indications were approved by @FDAOncology@twitter.com for Breast Cancer and 2 for Gyn Onc in 2022. Here is a summary!
- #TDXd x 2
- #Olaparib
- #Pembrolizumab
- #Mirvetuximab
#bcsm #gynsm @OncoAlert@twitter.com #breastcancer #MedTwitter #OncEd #MedEd #ovariancancer
🐦🔗: https://twitter.com/OncBrothers/status/1607753014521262081
#tdxd #olaparib #pembrolizumab #Mirvetuximab #bcsm #GYNSM #breastcancer #medtwitter #OncEd #MedEd #ovariancancer
Oncology Brothers · @OncBrothers
12 followers · 2 posts · Server med-mastodon.com
#Mirvetuximab soravtansine-gynx now #FDA approved for FRα +ve, platinum-resistant epithelial ovarian, Fallopian tube, or 1° peritoneal Ca post 1-3L of Rx.
- Assay-Ventana FOLR1 (FOLR-2.1)
- #SORAYA: Ph3, n=106, ORR 31.7%, CR:4.8%, mDOR of 6.9 mos
#Mirvetuximab #FDA #SORAYA #oncology #OncEd #GYNSM #CME #AntibodyDrugConjugate